CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionGlen Eagle Advisors, LLC
Latest Disclosed Ownership332 shares
Latest Disclosed Value $ 98,059
Glen Eagle Advisors, LLC ownership in MX4A / CME Group Inc.

On May 15, 2026 - Glen Eagle Advisors, LLC filed a 13F-HR form disclosing ownership of 332 shares of CME Group Inc. (DE:MX4A) valued at $84,809 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 332 shares of CME Group Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $72,310 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CME GROUP COM 12572Q105 332 0 0.00 98 8.89 0.0137
2026-02-13 2025-12-31 13F CME GROUP COM 12572Q105 332 1 0.30 91 1.12 0.0123
2025-11-14 2025-09-30 13F CME GROUP COM 12572Q105 331 0 0.00 90 -2.20 0.0124
2025-08-14 2025-06-30 13F CME GROUP COM 12572Q105 331 0 0.00 91 4.60 0.0140
2025-05-15 2025-03-31 13F CME GROUP COM 12572Q105 331 -32 -8.82 88 3.57 0.0145
2025-02-18 2024-12-31 13F CME GROUP COM 12572Q105 363 -50 -12.11 84 -7.69 0.0140
2024-11-15 2024-09-30 13F CME GROUP COM 12572Q105 413 -149 -26.51 91 -17.27 0.0154
2024-08-14 2024-06-30 13F CME GROUP COM 12572Q105 562 20 3.69 110 -5.17 0.0202
2024-07-03 2024-03-31 13F CME GROUP COM 12572Q105 542 3 0.56 117 2.65 0.0221
2024-08-13 2023-12-31 13F CME GROUP COM 12572Q105 539 -23 -4.09 113 0.89 0.0236
2024-08-13 2023-09-30 13F CME GROUP COM 12572Q105 562 1 0.18 113 8.74 0.0261
2024-08-13 2023-06-30 13F CME GROUP COM 12572Q105 561 51 10.00 104 6.19 0.0239
2024-08-13 2023-03-31 13F CME GROUP COM 12572Q105 510 47 10.15 98 25.97 0.0245
2024-08-13 2022-12-31 13F CME GROUP COM 12572Q105 463 48 11.57 78 5.48 0.0213
2024-08-13 2022-09-30 13F CME GROUP COM 12572Q105 415 64 18.23 73 2.82 0.0213
2024-08-13 2022-06-30 13F CME GROUP COM 12572Q105 351 0 0.00 72 -14.46 0.0195
2024-08-13 2022-03-31 13F CME GROUP COM 12572Q105 351 56 18.98 83 23.88 0.0218
2024-08-13 2021-12-31 13F CME GROUP COM 12572Q105 295 1 0.34 67 19.64 0.0175
2024-08-13 2021-09-30 13F CME GROUP COM 12572Q105 294 0 0.00 57 -9.68 0.0165
2024-08-13 2021-06-30 13F CME GROUP COM 12572Q105 294 0 0.00 63 3.33 0.0194
2024-08-13 2021-03-31 13F CME GROUP COM 12572Q105 294 1 0.34 60 13.21 0.0210
2024-08-13 2020-12-31 13F CME GROUP COM 12572Q105 293 0 0.00 53 10.42 0.0210
2024-08-13 2020-09-30 13F CME GROUP COM 12572Q105 293 -19 -6.09 49 -4.00 0.0219
2024-08-13 2020-06-30 13F CME GROUP COM 12572Q105 312 179 134.59 51 127.27 0.0261
2024-08-13 2020-03-31 13F CME GROUP CME GROUP INC 12572Q105 133 86 182.98 23 144.44 0.0161
2024-08-13 2019-12-31 13F CME GROUP COM 12572Q105 47 -10 -17.54 9 -25.00 0.0050
2024-08-13 2019-09-30 13F CME GROUP COM 12572Q105 57 0 0.00 12 9.09 0.0080
2024-08-13 2019-06-30 13F CME GROUP COM 12572Q105 57 6 11.76 11 37.50 0.0076
2024-08-13 2019-03-31 13F CME GROUP COM 12572Q105 51 -19 -27.14 8 -38.46 0.0061
2024-08-13 2018-12-31 13F CME GROUP COM 12572Q105 70 0 0.00 13 18.18 0.0111
2024-08-13 2018-09-30 13F CME GROUP COM 12572Q105 70 0 0.00 12 0.00 0.0085
2024-08-13 2018-06-30 13F CME GROUP COM 12572Q105 70 19 37.25 11 37.50 0.0090
2024-08-14 2018-03-31 13F/A-1 CME GROUP CME GROUP INC 12572Q105 51 0 0.00 8 14.29 0.0068
2024-08-13 2018-03-31 13F CME GROUP COM 12572Q105 8,246 8,195 8 0.0068
2024-08-13 2017-12-31 13F CME GROUP COM 12572Q105 51 0 0.00 7 16.67 0.0065
2024-08-13 2017-09-30 13F CME GROUP COM 12572Q105 51 5 10.87 7 -33.33 0.0065
2024-08-13 2017-06-30 13F CME GROUP COM 12572Q105 46 -2 -4.17 10 0.00 0.0076
2024-08-13 2017-03-31 13F CME GROUP COM 12572Q105 48 -74 -60.66 9 -35.71 0.0078
2024-08-13 2016-12-31 13F CME GROUP COM 12572Q105 122 122 14 0.0127
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.